Longitudinal Study Evaluating Recovery After Scheduled Cesarean Delivery
NCT04462107 is an observational study sponsored by Mayo Clinic. As of 18 Nov 2026, it is completed. It studies Cesarean Section. The registry lists an enrollment of 66 participants at 1 site in 1 country. The registry lists a start date of 1 Feb 2021 and a primary completion date of 1 Nov 2021.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04462107 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Mayo Clinic |
| Enrollment | 66 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Cesarean Section |
| Start | 1 Feb 2021 |
| Primary completion | 1 Nov 2021 |
| Study completion | 1 Nov 2021 |
| Last update posted | 28 Jan 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Emily E Sharpe, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Rochester
Rochester
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04462107
Each answer restates registry values shown on this page.
What is NCT04462107?
NCT04462107 is an observational study sponsored by Mayo Clinic. It studies Cesarean Section.
Who leads NCT04462107?
The registry names Emily E Sharpe, MD (principal investigator, Mayo Clinic) as the overall official.
Where does NCT04462107 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04462107 end?
The registry lists a primary completion date of 1 Nov 2021 and a study completion date of 1 Nov 2021. The sponsor last updated the record on 28 Jan 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.